drugset / Trial / NCT07311564
A Study of LAD603 in Adults With Alopecia Areata
RandomizedParallel-groupDouble-blindTreatment
Summary
The main aim of the study is to evaluate the effect of LAD603 in adult participants with severe to very severe alopecia areata (AA). The study will also evaluate the safety, pharmacokinetics (PK), immunogenicity and pharmacodynamic (PD) biomarkers of LAD603.
Timeline
- Start
- 2025-12-17
- Primary completion
- 2027-06-23
- Completion
- 2027-11-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LAD603 | Unknown | — | Subcutaneous |